Yahoo
NasdaqGS - Delayed Quote USD

Henry Schein, Inc. (HSIC)

89.81 -1.05 (-1.16%)
At close: September 4 at 4:00:01 PM EDT
89.81 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade HSIC on Coinbase
Chart Range Bar
Loading chart for HSIC

What's happening with HSIC?

55m ago
Powered by Yahoo Scout

Henry Schein (HSIC) is positioned as a strong growth and value stock, supported by robust earnings growth and favorable valuation metrics. Analysts expect continued revenue and EPS growth, while the company's recent partnerships enhance its market position.

Powered by Yahoo Scout
  • Previous Close 90.86
  • Open 89.91
  • Bid 82.77 x 200
  • Ask 97.58 x 200
  • Day's Range 89.64 - 90.54
  • 52 Week Range 61.95 - 92.18
  • Volume 774,004
  • Avg. Volume 1,251,458
  • Market Cap (intraday) 10.009B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 26.49
  • EPS (TTM) 3.39
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 98.19

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

www.henryschein.com

25,000

Full Time Employees

December 27

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HSIC
18.83%
S&P 500 (^GSPC)
12.75%

1-Year Return

HSIC
32.50%
S&P 500 (^GSPC)
18.71%

3-Year Return

HSIC
17.63%
S&P 500 (^GSPC)
70.93%

5-Year Return

HSIC
14.58%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.46B
Earnings 94M
Profit Margin 2.72%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
2.8%
2.9%
3.0%
3.1%

Analyst Insights

View More

Analyst Price Targets

64.00 Low
98.19 Average
89.81 Current
112.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/19/2026
Analyst BTIG
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 100 -> 110

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.96%

  • Return on Assets (ttm)

    4.39%

  • Return on Equity (ttm)

    8.85%

  • Revenue (ttm)

    13.6B

  • Net Income Avi to Common (ttm)

    403M

  • Diluted EPS (ttm)

    3.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157M

  • Total Debt/Equity (mrq)

    80.73%

  • Levered Free Cash Flow (ttm)

    446M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: